Agree. I think we have a long way to go before product validation on breast/hernia but hopefully will get some guidance on this in the near term future. I believe personally that this isn't being priced into the stock at all in any way shape or form so this will only be upside in the future. I think a big chunk of the valuation or at least majority is on the use cases infront of us today.
dogz - sorry to hear about your Mum's scenario - sounds awful. Hopefully as these technologies continue to improve in this space that outcomes can be improved around aesthetics. Looks like PNV has been successful at this up to this point
Agree. I think we have a long way to go before product...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |